IP Library Granted Patent US 8,137,903
Granted Patent B2
US 8,137,903 · App. 12/335,748 · Granted Mar 20, 2012

Method for magnetic separation of red blood cells from a patient sample

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,137,903
App. No.
12/335,748
Granted
Mar 20, 2012
Kind
B2
Abstract

A method for separating components from a patient sample is provided. In particular, the present invention provides a method for the separation of red blood cells or red blood cell components from a patient sample by the use of magnetic beads.

Claims (31)

1. A method of separating red blood cells or red blood cell fragments from other components of a biological sample in a specimen container the method comprising the steps of:

i.) adding to a specimen container a biological sample containing red blood cells or red blood cell fragments, which specimen container comprises an inner sleeve and an outer sleeve defining an internal compartment therebetween containing magnetic beads, said magnetic beads comprising a binder capable of selectively binding to red blood cells or red blood cell fragments;

ii.) removing said inner sleeve from said outer sleeve thus allowing said magnetic beads to come into fluid contact with said biological sample;

iii.) allowing the magnetic beads to selectively bind to the red blood cells or red blood cell fragments in the specimen container;

iv.) positioning a magnetic field in close proximity to the magnetic beads in the specimen container such that the beads are manipulated to the inner wall of the outer sleeve by the magnetic field; and

v.) reinserting said inner sleeve into said outer sleeve such that the red blood cells or red blood cell fragments separate from other cellular components of the patient sample in the specimen container.

2. The method of claim 1 wherein the biological sample comprises cervical cells.

3. The method of claim 1 wherein the biological sample is suspended in a cell preservative solution.

4. The method of claim 1 wherein the magnetic beads are immobilized by the magnetic field to the inner surface of the specimen container within an integrated compartment.

5. The method of claim 1 wherein red blood cells or red blood cell fragments are manipulated from other cell components in the biological sample by removing the magnetic beads from the specimen container by the magnetic field after the magnetic beads have selectively bound to the red blood cells or the red blood cell fragments.

6. The method of claim 1 wherein the magnetic beads are paramagnetic.

7. A method of separating red blood cells or red blood cell fragments from other cellular components in specimen container containing cells of a patient specimen, the method comprising the steps of:

i.) adding to a specimen container a patient specimen comprising red blood cells or red blood cell fragments, which specimen container comprises as inner sleeve and an outer sleeve defining an internal compartment therebetween containing magnetic beads, said magnetic beads comprising a binder capable of selectively binding to red blood cells or red blood cell fragments;

ii.) removing said inner sleeve from said outer sleeve thus allowing said magnetic beads to come into fluid contact with said biological sample;

iii.) allowing the magnetic beads to selectively bind to hemoglobin in the red blood cells or red blood cell fragments;

iv.) positioning a magnetic field in close proximity to the magnetic beads in the specimen container such that the magnetic beads are manipulated towards the magnet field;

whereby the manipulation of the magnetic beads towards the magnetic field results in the red blood cells or red blood cell fragments separating from other cellular components of the patient specimen in the specimen container.

8. The method of claim 7 wherein the patient sample comprises cervical cells.

9. The method of claim 7 wherein the patient sample is suspended in a cell preservative solution.

10. The method of claim 7 wherein the magnetic beads are immobilized by the magnetic field to the inner surface of the specimen container or within an integrated compartment.

11. The method of claim 7 wherein red blood cells or red blood cell fragments are separated from other cell components in the patient sample by removing the magnetic beads from the specimen container by the magnetic field after the magnetic beads have selectively bound to the red blood cells or the red blood cell fragments.

12. The method of claim 7 wherein the magnetic beads are paramagnetic.

13. A method of separating red blood cells or red blood cell fragments from other cellular components in specimen container containing cervical cells suspended in a preservative fluid, the method comprising the steps of:

i.) adding to a specimen container a patient specimen comprising red blood cells or red blood cell fragments, which specimen container comprises as inner sleeve and an outer sleeve defining an internal compartment therebetween containing magnetic beads, said magnetic beads comprising aptamers specific to hemoglobin bound thereto;

ii.) removing said inner sleeve from said outer sleeve thus allowing said magnetic beads to come into fluid contact with said biological sample;

iii.) allowing the magnetic beads to selectively bind to hemoglobin in the red blood cells or red blood cell fragments;

iv.) positioning a magnetic field in close proximity to the magnetic beads in the specimen container such that the magnetic beads are manipulated towards the magnet field;

whereby the manipulation of the magnetic beads towards the magnetic field results in the red blood cells or red blood cell fragments separating from other cellular components of the patient specimen in the specimen container.

14. The method of claim 13 wherein the magnetic beads are immobilized by the magnet to the inner surface of the specimen container or within an integrated compartment.

15. The method of claim 13 wherein red blood cells or red blood cell fragments are separated from other cell components in the patient sample by removing the paramagnetic beads from the specimen container by the magnet after the magnetic beads have selectively bound to the red blood cells or the red blood cell fragments.

16. The method of claim 13 wherein the magnetic beads are paramagnetic.

Assignments (9)
RELEASE OF SECURITY INTEREST Recorded Apr 28, 2026
From: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
To: HOLOGIC, INC., ON ITS OWN BEHALF AND AS SUCCESSOR-BY-MERGER TO DIRECT RADIOGRAPHY CORP.; CYTYC CORPORATION, ON ITS OWN BEHALF AND AS SUCCESSOR-BY-MERGER TO BIOLUCENT, LLC; CYTYC SURGICAL PRODUCTS, LLC, AS SUCCESSOR-BY-CONVERSION TO CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; GEN-PROBE INCORPORATED, ON ITS OWN BEHALF AND AS SUCCESSOR-BY-MERGER TO THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE PRODESSE, INC.; SUROS SURGICAL SYSTEMS, INC.
Reel/Frame 075566/0039 →
CORRECTIVE ASSIGNMENT TO CORRECT THE INCORRECT PATENT NO. 8081301 PREVIOUSLY RECORDED AT REEL: 035820 FRAME: 0239. ASSIGNOR(S) HEREBY CONFIRMS THE SECURITY INTEREST RELEASE. Recorded Nov 9, 2017
From: GOLDMAN SACHS BANK USA, AS COLLATERAL AGENT
To: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE INCORPORATED
Reel/Frame 044727/0529 →
CORRECTIVE ASSIGNMENT TO CORRECT THE INCORRECT PATENT NO. 8081301 PREVIOUSLY RECORDED AT REEL: 028810 FRAME: 0745. ASSIGNOR(S) HEREBY CONFIRMS THE SECURITY AGREEMENT. Recorded Nov 9, 2017
From: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE INCORPORATED
To: GOLDMAN SACHS BANK USA
Reel/Frame 044432/0565 →
SECURITY AGREEMENT Recorded Aug 7, 2015
From: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; DIRECT RADIOGRAPHY CORP.; GEN-PROBE INCORPORATED; GEN-PROBE PRODESSE, INC.; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 036307/0199 →
SECURITY INTEREST RELEASE REEL/FRAME 028810/0745 Recorded Jun 4, 2015
From: GOLDMAN SACHS BANK USA, AS COLLATERAL AGENT
To: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE INCORPORATED
Reel/Frame 035820/0239 →
SECURITY AGREEMENT Recorded Aug 1, 2012
From: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE INCORPORATED
To: GOLDMAN SACHS BANK USA
Reel/Frame 028810/0745 →
TERMINATION OF PATENT SECURITY AGREEMENTS AND RELEASE OF SECURITY INTERESTS Recorded Aug 26, 2010
From: GOLDMAN SACHS CREDIT PARTNERS, L.P., AS COLLATERAL AGENT
To: HOLOGIC, INC.; R2 TECHNOLOGY, INC.; SUROS SURGICAL SYSTEMS, INC.; BIOLUCENT, LLC; DIRECT RADIOGRAPHY CORP.; CYTYC SURGICAL PRODUCTS II LIMITED PARTNERSHIP; CYTYC SURGICAL PRODUCTS LIMITED PARTNERSHIP; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS III, INC.; CYTYC PRENATAL PRODUCTS CORP.; THIRD WAVE TECHNOLOGIES, INC.
Reel/Frame 024892/0001 →
SIXTH SUPPLEMENT TO PATENT SECURITY AGREEMENT Recorded Jan 27, 2009
From: CYTYC CORPORATION
To: GOLDMAN SACHS CREDIT PARTNERS L.P., AS COLLATERAL AGENT
Reel/Frame 022163/0844 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 16, 2008
From: KAUFMAN, HOWIE; BURG, LAWRENCE
To: CYTYC CORPORATION
Reel/Frame 021988/0279 →